about
Acupuncture for migraine prophylaxisAcupuncture for tension-type headacheMigraine during pregnancy and lactation: treatment of the acute attack and non-pharmacological prophylactic strategiesThe diagnostic iter of patent foramen ovale in migraine patients: an update.Treatment of aura: solving the puzzle.Gender and triptan efficacy: a pooled analysis of three double-blind, randomized, crossover, multicenter, Italian studies comparing frovatriptan vs. other triptans.Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura.Acupuncture treatment as breastfeeding support: preliminary data.Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan.Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian studyAcupuncture for idiopathic headache.Joint Metabonomic and Instrumental Analysis for the Classification of Migraine Patients with 677-MTHFR Mutations.Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres.Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized study.Efficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studies.Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial.Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan.Oral contraceptives in women with migraine: balancing risks and benefits.Update on menstrual migraine: from clinical aspects to therapeutical strategies.Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.Acupressure in the control of migraine-associated nauseaFrovatriptan versus zolmitriptan for the acute treatment of migraine with aura: a subgroup analysis of a double-blind, randomized, multicenter, Italian studyMigraine with aura from pathophysiology to treatment: therapeutic strategies.Early triptan intervention in migraine: an overview.A review of the use of frovatriptan in the treatment of menstrually related migraine.Is migraine a risk factor in pregnancy?Frovatriptan plus dexketoprofen in the treatment of menstrually related migraine: an open studyFrovatriptan vs. other triptans for the acute treatment of oral contraceptive-induced menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.Menstrual migraine: clinical and therapeutical aspects.Migraine and stroke: the role of oral contraceptives.Oral contraceptives in migraine.Clinical review of headache in pregnancy.The risks of women with migraine during pregnancy.Non-pharmacological management of migraine during pregnancy.Non-pharmacological approach to migraine prophylaxis: part II.Acupuncture in primary headache treatment.Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies.Almotriptan for menstrually related migraine.Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea.
P50
Q24241053-B1C3A0FA-13DA-48D6-89A9-D62B78FD7B2BQ24241195-DAD0BE6F-F5EF-45E2-952E-988B80C39380Q28168401-B4FA81BE-E4B3-4914-B18B-1894F3D46B3CQ31158799-60A961F8-A069-4836-B23B-4364C5518EBFQ33342587-B1A06BCC-359B-44CD-8AAB-55EF5A4E761FQ33671813-BAAEA1BC-ACD8-40C0-BB49-9C40441524B5Q33671824-5BE70928-9A58-4449-B00D-0338393E5473Q33814762-2135563B-2CCF-4479-B626-691F36E82631Q33847251-E0564BDE-0575-4629-88E7-4B5CC2CF60FBQ33847333-EE79CBDA-2888-44F7-9159-EE18BC2D2E86Q33940713-DFB8C507-33B6-4D3E-9672-6C2553B91D1DQ34044774-7E4B2F9E-B301-439C-B72A-3EA75F57C9BBQ34341673-2CF497FF-45C3-4BA1-A206-C36A206A7A12Q34393819-ECBC5603-649D-4BBA-AD79-4D1849F4BF7AQ34421615-9F4E30E0-A486-44FA-B675-661D3EF728F2Q34664152-F5954E76-6777-4F8D-AF60-B1B7FC0CDCC6Q34673690-A1916CBC-66E5-4352-893F-DC7F23935AC7Q34890784-8F678D2F-B4EC-46D4-B399-AEB5E5012854Q35953510-E735CF00-582E-4FDA-ADDC-F9AB6F2FC827Q35953528-30DD4BD0-D5C7-4B1D-9581-F036B513CA3FQ35996147-516AA13F-76B1-4A40-857F-76405290F010Q35996164-2AC85713-60E0-4273-8478-0777ECF86396Q35996223-DB8E4C4A-3C80-412D-BD53-EC1D31E96F0DQ36145399-DF81296C-2B65-4100-A1BD-832F69FE3677Q36145404-498711D3-FE1D-4E0D-81F9-EB8551DF4F8AQ36638660-A52D50DB-D818-483D-BCD9-752074E026F3Q36824676-39155978-0C73-40F6-8F64-4192B118902FQ36865915-ADF67FEF-9F87-4359-8DF2-F9B4316B3E62Q36865920-ABF9E72E-83B4-479F-8319-537C9D15B2AAQ36941893-6D2A2DF8-62A3-47D2-93DC-4D6903276AFDQ37188595-5CF05C98-CA98-4642-A009-F7F32F3A8C7DQ37409501-24BCC615-0641-47B3-9848-00E934F82E3AQ37750559-D088EA81-7F54-4DC6-B55E-0B5910518330Q37750560-E0C93B1B-B2A0-4350-B74D-4E6373FD1438Q37750562-42316427-6AF9-45F6-A84B-C49A20E9BEE2Q37750607-74A14E37-E946-4878-9763-E46F42A49AE4Q37870780-0B84BF68-74F0-49BE-830C-FC25A0F7CFC4Q37870791-D688FE2A-EA7A-431F-8AFE-60FB0DDFEB52Q37897224-457E56B4-2AFE-4912-A98B-E12CAA43A5FFQ37939992-351EB727-BED0-4B7C-918D-4B84C03A3B0F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gianni Allais
@ast
Gianni Allais
@en
Gianni Allais
@es
Gianni Allais
@nl
type
label
Gianni Allais
@ast
Gianni Allais
@en
Gianni Allais
@es
Gianni Allais
@nl
prefLabel
Gianni Allais
@ast
Gianni Allais
@en
Gianni Allais
@es
Gianni Allais
@nl
P106
P1153
7003885201
P21
P31
P496
0000-0002-1946-0109